GPT and diabetes mellitus: Meta-analyses show that Fib-4 and NFS outperform other commonly used noninvasive scores such as the AST/platelet ratio index and the BARD (BMI ≥ 28 = 1 point, AST/ALT ratio of ≥ 0.8 = 2 points, diabetes mellitus = 1 point) score in predicting fibrosis progression, liver-related events, and mortality [95,96].